Evidence map›Paper›PMID 33539790›Full record

ArticleBiophysical journal2021

Length of mucin-like domains enhances cell-Ebola virus adhesion by increasing binding probability.

Xinyu Cui, Nicole Lapinski, Xiaohui Frank Zhang, Anand Jagota

Open access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 61% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Xinyu CuiDepartment of Bioengineering.
Nicole LapinskiDepartment of Chemical and Biomolecular Engineering.
Xiaohui Frank ZhangDepartment of Bioengineering; Department of Mechanical Engineering and Mechanics, Lehigh University, Bethlehem, Pennsylvania.
Anand JagotaDepartment of Bioengineering; Department of Chemical and Biomolecular Engineering. Electronic address: anj6@lehigh.edu.
Bioengineering Center · RULehigh University · US

Funding

Biomechanics of TIM Protein-Mediated Ebola Virus-Host Cell AdhesionR15AI133634 · NIAID · LEHIGH UNIVERSITY · PI JAGOTA, ANAND, ZHANG, XIAOHUI · 2018 to 2018
$435k
NIAID NIH HHS R15 AI133634
6 · The paper itself

Abstract

The Ebola virus (EBOV) hijacks normal physiological processes by apoptotic mimicry to be taken up by the cell it infects. The initial adhesion of the virus to the cell is based on the interaction between T cell immunoglobulin and mucin domain protein, TIM, on the cell surface and phosphatidylserine (PS) on the viral outer surface. Therefore, it is important to understand the interaction between EBOV and PS and TIM, with selective blocking of the interaction as a potential therapy. Recent experimental studies have shown that for TIM-dependent EBOV entry, a mucin-like domain with a length of at least 120 amino acids is required, possibly because of the increase of area of the PS-coated surface sampled. We examine this hypothesis by modeling the process of TIM-PS adhesion using a coarse-grained molecular model. We find that the strength of individual bound PS-TIM pairs is essentially independent of TIM length. TIMs with longer mucin-like domains collectively have higher average binding strengths because of an increase in the probability of binding between EBOV and TIM proteins. Similarly, we find that for larger persistence length (less flexible), the average binding force decreases, again because of a reduction in the probability of binding.

Indexed as

EbolavirusHemorrhagic Fever, EbolaHumansMucinsProbabilityReceptors, VirusMucinsReceptors, Virus

Identifiers

PMID33539790
PMCPMC8008262
OpenAlexW3127775696

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.